ELV insider buying and SEC filings, explained
Elevance Health, Inc. · CIK 1156039
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$2.2M
Insiders who bought
3
Sold (not marked 10b5-1)
$5.8M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 22, 2026 | Sale | Mark Kaye (CFO) sold 10,584 shares at about $440.13 ($4.7M). Holdings down 35% to 19,919 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 23, 2026, 4:30 PM ET |
| Jul 17, 2026 | Purchase (code P) | Gail Boudreaux (CEO and Director) bought 2,725 shares at about $367.79 ($1.0M), reported as a purchase (code P). Holdings up 2% to 171,976 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 17, 2026 |
| Jul 17, 2026 | Purchase (code P) | Ramiro G. Peru (Director) bought 1,000 shares at $366.05 ($366K), reported as a purchase (code P). Holdings up 10% to 10,908 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 17, 2026 |
| Jun 12, 2026 | Sale | Ronald W Penczek (CAO & Controller) sold 369 shares at about $403.16 ($149K). Holdings down 9% to 3,740 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 15, 2026 |
| Jun 11, 2026 | Sale | Robert L Dixon JR (Director) sold 151 shares at $401.77 ($61K). Holdings down 1% to 10,734 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 12, 2026 |
| Mar 12, 2026 | Sale | Amy W. Schulman (Director) sold 26 shares at $287.50 ($7K). Holdings down 11% to 218 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 23, 2026 |
| Mar 6, 2026 | Sale | Charles Morgan Kendrick JR (President / COO) sold 3,196 shares at about $284.92 ($911K). Holdings down 21% to 11,791 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Mar 5, 2026 | Purchase (code P) | Steven H. Collis (Director) bought 3,000 shares at $289.84 ($870K), reported as a purchase (code P). Holdings up 469% to 3,639 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 6, 2026 |
26 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
2 insiders bought in 30 days
$1.4M in purchases since Jul 17, 2026 · Purchases traded Jul 17, 2026 to Jul 17, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Ramiro G. Peru (Director) | $366K | Jul 17, 2026 | SEC filing |
| Gail Boudreaux (CEO) | $1.0M | Jul 17, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ELV in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.